To discourage the spread of infection, FDA has ordered manufacturers of multi-dose insulin pens to display the warning “For single patient use only” on all materials connected with the products.
The Office of Disease Prevention and Health Promotion under the Department of Health and Human Services (HHS) is calling for public review and comments on its draft plan to reduce adverse drug events that are preventable. The deadline is Friday, Oct. 4 to email feedback to [email protected]